Cardiovascular disease (general) Clinical Trials in Riverview, FL
As of July 2026, 1 paid clinical trial is recruiting for Cardiovascular disease (general) in Riverview, Florida. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Riverview
Filter results
1 clinical trial for Cardiovascular disease (general)
·Clear filters·Top Research Study Locations in Riverview
Researchers run research studies in Riverview, FL at 12 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Equipath Health and Research Tampa Bay, Llc | Major Depressive Disorder | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Covenant Metabolic Specialist, LLC - Riverview | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
| Florida Kidney Physicians - Riverview/Brandon | Focal Segmental Glomerulosclerosis, Proteinuric Kidney Diseases | 2 |
| Southwest Florida Rheumatology | Psoriatic Arthritis, Rheumatoid Arthritis | 2 |
| Florida Kidney Physicians | Lupus Nephritis | 1 |
| Covenant Metabolic Specialists - Riverview | Metabolic Dysfunction-Associated Steatotic Liver Disease | 1 |
| Covenant Metabolic Specialists, LLC - Brandon | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| EquiPath Health & Research Tampa Bay, LLC | Major Depressive Disorder | 1 |
| Florida Urology Partners | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 1 |
| NRSA Group (Florida Spine & Pain Specialists) | Degenerative Disc Disease (DDD) | 1 |
| Panoramic Health - Florida Kidney Physicians, LLC (Tampa) | Kidney Disease | 1 |
Active & Upcoming Studies in Riverview (2026)
Recruiting trials in Riverview grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Diabetes & metabolic (3 active studies)
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
- A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH · Phase 3 · Akero Therapeutics, Inc
Cardiovascular (2 active studies)
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure · Phase 3 · AstraZeneca
Cancer & tumors (1 active study)
Common conditions studied in Riverview
- Major Depressive Disorder (4 active studies)
- Cardiovascular Diseases (1 active study)
- Chronic Kidney Disease and Hypertension (1 active study)
- Degenerative Disc Disease (DDD) (1 active study)
- Diabetes Mellitus, Type 2 (1 active study)
- Focal Segmental Glomerulosclerosis (1 active study)
Leading research sponsors in Riverview
- Boehringer Ingelheim
- Akero Therapeutics, Inc
- Xenon Pharmaceuticals Inc.
- AbbVie
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Riverview?
There are approximately 19 recruiting clinical trials in Riverview, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Riverview pay participants?
Most recruiting trials in Riverview compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Riverview?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Riverview?
The most common conditions under active study in Riverview include Major Depressive Disorder (4), Cardiovascular Diseases (1), Chronic Kidney Disease and Hypertension (1), Degenerative Disc Disease (DDD) (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Riverview?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Riverview on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Riverview?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Riverview?
Recruiting research sites in Riverview include Equipath Health and Research Tampa Bay, Llc, Akero Clinical Study Site, Covenant Metabolic Specialist, LLC - Riverview, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Riverview right now?
The largest active categories in Riverview are Diabetes & metabolic (3), Cardiovascular (2), Cancer & tumors (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.